COVID-19 vaccine hesitancy in periconceptional and lactating women: a systematic review and meta-analysis protocolArticle Published on 2022-11-072022-11-16 Journal: BMJ Open [Category] meta-analysis, [키워드] Analysis appear approval article caused CNKI Cochrane Library COVID-19 COVID-19 vaccine criteria data extraction determinant discrepancy disease effective Embryology Epidemiology Ethics Evidence gestation heterogeneity higher risk homogeneous indicated lack lactating lactating women lactation Meta-analysis meta-regression observational study outcome outcomes pandemic pandemic of COVID-19 peer-reviewed Pregnancy pregnant pregnant women Prevalence PROSPERO protocol provided receive reproductive reproductive medicine required Research resolved subject systematic review vaccination Vaccine hesitancy Web of Science WHO with COVID-19 women [DOI] 10.1136/bmjopen-2021-059514 PMC 바로가기
SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participantsArticle Published on 2022-10-032022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, [키워드] addition adenovirus vaccine Analysis anti-SARS-CoV-2 IgG Anti-spike AstraZeneca BBIBP-CorV Blood Breastfeeding breastmilk ChAdOx1-S children Cohort convalescent COVID-19 COVID-19 vaccine cross-sectional decrease eligible evaluated IgA IgA level IgA response IgG IgG level immune response inactivated Infection information lactating lactating women mother mRNA naïve Newborn no significant difference Oxford participant passive immunity positive receive receiving recent SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2-specific antibody second dose serum serum sample shown significantly higher Sinopharm Sputnik V vaccination Vaccine vaccine platform Vaccines women [DOI] 10.3389/fimmu.2022.909995 PMC 바로가기
Maternal mental health and breastfeeding amidst the Covid-19 pandemic: cross-sectional study in Catalonia (Spain)Article Published on 2022-09-262022-11-16 Journal: BMC Pregnancy and Childbirth [Category] SARS, 치료기술, [키워드] abnormality adverse outcome Affect age Anxiety bonding Breastfeeding carried conducted COVID-19 cross-sectional cut-off Depressive symptoms detect Edinburgh emotional enrolled First wave Follow-up health emergency hospital increase in infectious risk lactating lockdown Maternal Maternal mental health. mental health mother Neonatal Newborn outcome pandemic Postpartum pregnant women prospective observational study scale significant increase Spain step Study design women [DOI] 10.1186/s12884-022-05036-9 PMC 바로가기
Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2Article Published on 2022-09-122022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, [키워드] antibody asked B.1.1.7 B.1.351 Beta binding Blood breast milk breast permeability breastmilk CCR7 CD4 CD45RO CD8 T cell Cell complex COVID-19 COVID-19 vaccine D614G domain dried blood spot effector memory elect enrolled expressed first COVID-19 symptom flow cytometry Gamma IgA IgA response IgG IgM Immunity Immunoglobulin indicated Infant lactating memory memory T memory T cells milk mother mucosal mucosal immunity neutralize neutralized Neutralizing P.1 participant passive immunity permeability positive potassium ion pregnant women Protective reactivity receive robust SARS-CoV-2 SARS-COV-2 infection second set significantly higher sodium Stool T cell T cell response tested the spike protein timepoint was collected were assessed women [DOI] 10.3389/fimmu.2022.985226 PMC 바로가기
Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion인간 유아 위장 소화를 통한 백신 유도 모유 SARS-CoV-2 IgG, IgA 및 SIgA 면역글로불린의 생존Article Published on 2022-08-172022-09-12 Journal: Nutrients [Category] SARS, 진단, [키워드] adenovirus-based antibody Breastfeeding breastmilk COVID-19 COVID-19 pandemic Degradation digestion dose evaluated Evidence Gastrointestinal GI Tract help Human human milk IgA IgA antibody IgG Immunoglobulin immunoglobulins in vitro Inconclusive Infant information intestinal lactating milk mother mRNA-based vaccine natural infection passive immunity persistence Pfizer/BioNTech produced PROTECT protective role protocol recent reduced reduction SARS-CoV-2 SARS-CoV-2 IgG secretory IgA SIgA the SARS-CoV-2 virus the spike protein the vaccine transfer vaccination Vaccine women [DOI] 10.3390/nu14163368 PMC 바로가기 [Article Type] Article
Antibodies in the breastmilk of COVID-19 recovered women코로나19 회복된 여성의 모유에 있는 항체Article Published on 2022-08-112022-09-11 Journal: BMC Pregnancy and Childbirth [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome coronavirus anti-RBD IgA anti-SARS-CoV-2 IgG antibodies antibody antibody levels Asymptomatic benefit Breast breast milk Breastfeeding breastmilk characterized clinical symptom Clinical symptoms collected Concentration control group coronavirus coronavirus 2 COVID-19 COVID-19 disease enzyme enzyme-linked immunosorbent assay Human human milk IgA IgG IgG antibodies IgG antibody immunization immunoglobulins Immunoglobulins, passive immunity Infant Infants lactating mother no statistically significant difference passive immunity passive immunization positive protective factor RBD IgA respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test serum serum sample serum samples severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severity statistically significant difference symptomatic and asymptomatic symptomatic infection test result virus transmission was performed with COVID-19 women [DOI] 10.1186/s12884-022-04945-z PMC 바로가기 [Article Type] Article
Exclusion of Reproductive-Aged Women in COVID-19 Vaccination and Clinical TrialsResearch article Published on 2022-06-012022-10-05 Journal: Women's Health Issues [Category] COVID19(2023년), SARS, 신약개발, 임상, [키워드] Analysis analyzed association Breastfeeding childbearing potential clinical Clinical treatment clinical trial clinical trials Contraception coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine database excluded exclusion exclusion criteria global pandemic individual individuals lactating lactation library male Medicine participant Pregnancy pregnant profiles required Result Sponsor study participation Treatment treatment trials trials Vaccine [DOI] 10.1016/j.whi.2022.06.004 [Article Type] Research article
Overview of Breastfeeding Under COVID-19 PandemicCOVID-19 팬데믹 상황에서 모유 수유 개요Review Published on 2022-05-312022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] absence acute respiratory syndrome addition Antiviral benefit Breastfeeding breastmilk caused contribute coronavirus coronavirus disease country COVID-19 COVID-19 pandemic death global pandemic growth Guidance higher risk human milk incidence rate Infant infected with COVID-19 Infection inhibit international organization lactating lactating women lactoferrin mechanism mother pathogen pregnant PROTECT provided raised recommendation reduce risk SARS-CoV-2 SARS-CoV-2 specific antibody significantly Support Transmission vertical transmission virus [DOI] 10.3389/fimmu.2022.896068 PMC 바로가기 [Article Type] Review
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study건강한 성인에서 AS03 보조제 SARS-CoV-2 재조합 단백질 백신(CoV2 preS dTM)의 안전성 및 면역원성: 2상, 무작위, 용량 찾기, 다기관 연구의 중간 결과Clinical Trial Published on 2022-05-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 95% CI abstinence adjuvants Adults adverse event adverse events Adverse reaction Adverse reactions age All participant All participants antibody Antibody titre Antigen AS03 assessments assigned authority baseline booster vaccination candidate vaccine Chemotherapy childbearing potential clinical development Clinical research clinical trial Cohort Contraception COVID-19 vaccine D614G variant development dose effective Endpoint enrolled evaluated expected fixed Frequency geometric mean geometric mean titre GMT GMT ratio GMTs groups healthy High dose High-dose high-dose group Immunocompromised immunogenicity increase in increased risk injection injection site Injections intensity interim results investigator investigators involved Laboratory lactating low dose low-dose medical condition Medical conditions medium medium dose Mild mild to moderate moderate multicentre Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres occurred Older Older adults Organ transplant outcome outcome assessor outcome assessors parallel-group participant Participants Phase 2 Phase 3 positive prefusion pregnant primary immunogenicity progression proportion Protein protocol provided pseudovirus neutralisation assay randomised Randomly reactogenicity receive Registered reported Research research and development responses robust Safety safety analysis safety endpoints safety profile Sanofi Pasteur SARS-CoV-2 second dose second vaccination selected Serious Adverse Event Serious Adverse Events serodiagnostic Seven severe COVID-19 Stratification study period supported systemic test result titre titres Treatment treatment group treatment groups Trial USA vaccination Vaccine was done were excluded were measured yes or no [DOI] 10.1016/S1473-3099(21)00764-7 PMC 바로가기 [Article Type] Clinical Trial
Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study백신 접종 후 모유 내 Anti-SARS-CoV-2 IgA 및 IgG는 백신 유형 및 이전 SARS-CoV-2 노출에 따라 다릅니다. 종단 연구Observational Study Published on 2022-04-212022-09-12 Journal: Genome Medicine [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] age anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibodies antibody AstraZeneca baseline BNT162b2 Breast breast milk ChAdOx1 nCoV-19 collected Course COVID-19 COVID-19 vaccination COVID-19 vaccine dependent on distribution dose evaluate first dose group healthcare human milk IgA IgA antibodies IgA level IgG IgG antibody immunoglobulins Infant lactating lactating women Level Moderna mother mRNA vaccine mRNA-1273 mRNA-based vaccine persistence prospective observational study Protective Protective antibody reactivity receiving SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection second dose Seven significantly higher Spain the vaccine transfer vaccination Vaccine Vaccines virus women [DOI] 10.1186/s13073-022-01043-9 PMC 바로가기 [Article Type] Observational Study